 Benjamin Frank
Concepts (229)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypertension, Pulmonary | 14 | 2023 | 1771 | 3.030 |
Why?
| | Ventricular Dysfunction, Left | 6 | 2022 | 366 | 1.790 |
Why?
| | Heart Defects, Congenital | 7 | 2023 | 686 | 1.490 |
Why?
| | Hernias, Diaphragmatic, Congenital | 2 | 2023 | 189 | 1.450 |
Why?
| | Endothelin-1 | 2 | 2022 | 167 | 1.320 |
Why?
| | Fontan Procedure | 4 | 2023 | 151 | 1.140 |
Why?
| | Ventricular Dysfunction, Right | 4 | 2023 | 236 | 1.140 |
Why?
| | Cardiac Surgical Procedures | 5 | 2022 | 443 | 1.040 |
Why?
| | Matrix Metalloproteinase 8 | 1 | 2023 | 8 | 0.930 |
Why?
| | Blood Proteins | 2 | 2020 | 235 | 0.840 |
Why?
| | Aortic Coarctation | 2 | 2023 | 66 | 0.830 |
Why?
| | Heart Bypass, Right | 1 | 2022 | 15 | 0.820 |
Why?
| | Cardiac Catheterization | 3 | 2022 | 528 | 0.820 |
Why?
| | Infant, Premature, Diseases | 2 | 2023 | 91 | 0.810 |
Why?
| | Pulmonary Artery | 6 | 2021 | 1025 | 0.810 |
Why?
| | Echocardiography | 5 | 2023 | 564 | 0.800 |
Why?
| | Hemodynamics | 8 | 2022 | 982 | 0.760 |
Why?
| | Ventricular Function, Left | 4 | 2023 | 470 | 0.750 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2020 | 64 | 0.730 |
Why?
| | Cardiopulmonary Bypass | 6 | 2022 | 179 | 0.730 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2023 | 245 | 0.720 |
Why?
| | Heart Diseases | 1 | 2023 | 336 | 0.710 |
Why?
| | Heart Function Tests | 1 | 2019 | 59 | 0.700 |
Why?
| | Infant | 16 | 2023 | 8122 | 0.680 |
Why?
| | Scurvy | 1 | 2019 | 12 | 0.660 |
Why?
| | Interleukin-1 Receptor-Like 1 Protein | 1 | 2019 | 24 | 0.660 |
Why?
| | Bronchopulmonary Dysplasia | 2 | 2023 | 328 | 0.640 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2019 | 106 | 0.630 |
Why?
| | Child | 23 | 2023 | 18877 | 0.630 |
Why?
| | Diagnostic Imaging | 1 | 2020 | 294 | 0.610 |
Why?
| | Prospective Studies | 10 | 2023 | 6389 | 0.590 |
Why?
| | Ventricular Remodeling | 1 | 2019 | 234 | 0.570 |
Why?
| | Infant, Newborn | 11 | 2023 | 5170 | 0.520 |
Why?
| | Heart Ventricles | 6 | 2023 | 728 | 0.500 |
Why?
| | Humans | 44 | 2023 | 117051 | 0.450 |
Why?
| | Familial Primary Pulmonary Hypertension | 4 | 2022 | 191 | 0.450 |
Why?
| | Pain | 1 | 2019 | 719 | 0.440 |
Why?
| | Matrix Metalloproteinase 7 | 2 | 2023 | 23 | 0.420 |
Why?
| | Treatment Outcome | 9 | 2022 | 9257 | 0.400 |
Why?
| | Retrospective Studies | 11 | 2023 | 12825 | 0.400 |
Why?
| | Ventricular Function, Right | 3 | 2023 | 261 | 0.400 |
Why?
| | Pulmonary Veins | 2 | 2023 | 84 | 0.380 |
Why?
| | Atrial Function, Right | 2 | 2021 | 15 | 0.380 |
Why?
| | Myocardial Contraction | 3 | 2020 | 328 | 0.360 |
Why?
| | Postoperative Complications | 5 | 2021 | 2198 | 0.350 |
Why?
| | Adolescent | 12 | 2023 | 18214 | 0.340 |
Why?
| | Pulmonary Valve | 1 | 2010 | 91 | 0.340 |
Why?
| | Biomarkers | 5 | 2023 | 3549 | 0.330 |
Why?
| | Tissue Engineering | 1 | 2010 | 365 | 0.280 |
Why?
| | Magnetic Resonance Imaging, Cine | 3 | 2023 | 161 | 0.270 |
Why?
| | Proteomics | 2 | 2023 | 844 | 0.270 |
Why?
| | Hemorrhage | 2 | 2021 | 602 | 0.270 |
Why?
| | Vascular Stiffness | 2 | 2021 | 416 | 0.270 |
Why?
| | Predictive Value of Tests | 4 | 2023 | 1825 | 0.260 |
Why?
| | Hypoxia | 2 | 2022 | 950 | 0.250 |
Why?
| | Male | 18 | 2023 | 56663 | 0.250 |
Why?
| | Nitric Oxide | 2 | 2021 | 861 | 0.250 |
Why?
| | Acute Kidney Injury | 2 | 2022 | 690 | 0.240 |
Why?
| | Magnetic Resonance Imaging | 6 | 2023 | 3121 | 0.240 |
Why?
| | Prognosis | 2 | 2023 | 3390 | 0.230 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2023 | 25 | 0.230 |
Why?
| | Kynurenine | 2 | 2021 | 79 | 0.220 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2023 | 26 | 0.220 |
Why?
| | Stroke Volume | 2 | 2023 | 514 | 0.220 |
Why?
| | Tryptophan | 2 | 2022 | 138 | 0.220 |
Why?
| | Stenosis, Pulmonary Vein | 1 | 2023 | 17 | 0.220 |
Why?
| | Computed Tomography Angiography | 1 | 2023 | 93 | 0.220 |
Why?
| | Infant, Extremely Premature | 1 | 2023 | 59 | 0.220 |
Why?
| | Female | 17 | 2023 | 60634 | 0.210 |
Why?
| | Extracellular Matrix Proteins | 1 | 2023 | 130 | 0.210 |
Why?
| | Atrioventricular Block | 1 | 2022 | 31 | 0.210 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2022 | 37 | 0.210 |
Why?
| | Fetal Diseases | 1 | 2023 | 148 | 0.210 |
Why?
| | Phenylpropionates | 1 | 2022 | 17 | 0.210 |
Why?
| | Infant, Newborn, Diseases | 1 | 2023 | 106 | 0.200 |
Why?
| | Pyridazines | 1 | 2022 | 50 | 0.200 |
Why?
| | Phosphoproteins | 1 | 2003 | 299 | 0.200 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2021 | 15 | 0.200 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2003 | 494 | 0.200 |
Why?
| | Aorta, Thoracic | 1 | 2023 | 244 | 0.190 |
Why?
| | Ventricular Function | 1 | 2021 | 57 | 0.190 |
Why?
| | Postoperative Period | 1 | 2022 | 303 | 0.190 |
Why?
| | Administration, Inhalation | 2 | 2021 | 642 | 0.190 |
Why?
| | Pulmonary Atresia | 1 | 2020 | 7 | 0.190 |
Why?
| | Protein Conformation | 1 | 2003 | 833 | 0.190 |
Why?
| | Antihypertensive Agents | 2 | 2022 | 434 | 0.190 |
Why?
| | Matrix Metalloproteinases | 1 | 2021 | 89 | 0.180 |
Why?
| | Metabolomics | 3 | 2021 | 541 | 0.180 |
Why?
| | Risk Factors | 4 | 2023 | 8873 | 0.180 |
Why?
| | Preoperative Period | 1 | 2020 | 109 | 0.180 |
Why?
| | Heart Atria | 1 | 2021 | 110 | 0.180 |
Why?
| | Extracellular Matrix | 1 | 2023 | 446 | 0.170 |
Why?
| | Lung | 3 | 2023 | 3588 | 0.170 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 50 | 0.170 |
Why?
| | Intensive Care Units, Neonatal | 2 | 2018 | 181 | 0.170 |
Why?
| | Infant, Premature | 2 | 2023 | 478 | 0.170 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2020 | 111 | 0.170 |
Why?
| | Regional Blood Flow | 1 | 2021 | 413 | 0.170 |
Why?
| | Gingiva | 1 | 2019 | 22 | 0.170 |
Why?
| | Aortic Valve Stenosis | 1 | 2022 | 256 | 0.170 |
Why?
| | Coronary Care Units | 1 | 2018 | 14 | 0.170 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 85 | 0.160 |
Why?
| | Models, Cardiovascular | 1 | 2020 | 176 | 0.160 |
Why?
| | Cholecalciferol | 1 | 2019 | 48 | 0.160 |
Why?
| | Chest Pain | 1 | 2019 | 83 | 0.160 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 373 | 0.160 |
Why?
| | Alkaline Phosphatase | 1 | 2019 | 152 | 0.160 |
Why?
| | Ascorbic Acid | 1 | 2019 | 118 | 0.160 |
Why?
| | Endotoxemia | 1 | 2019 | 85 | 0.160 |
Why?
| | Endotoxins | 1 | 2019 | 208 | 0.150 |
Why?
| | Child, Preschool | 6 | 2022 | 9323 | 0.150 |
Why?
| | Heart Transplantation | 1 | 2023 | 661 | 0.150 |
Why?
| | Iron | 1 | 2019 | 242 | 0.150 |
Why?
| | Leg | 1 | 2019 | 228 | 0.150 |
Why?
| | Vasodilator Agents | 1 | 2019 | 311 | 0.140 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2018 | 475 | 0.140 |
Why?
| | Length of Stay | 2 | 2018 | 989 | 0.140 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2021 | 696 | 0.140 |
Why?
| | Case-Control Studies | 2 | 2020 | 3099 | 0.140 |
Why?
| | Down Syndrome | 1 | 2021 | 341 | 0.140 |
Why?
| | Tandem Mass Spectrometry | 1 | 2018 | 418 | 0.140 |
Why?
| | Risk | 1 | 2019 | 842 | 0.140 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 1997 | 99 | 0.140 |
Why?
| | Proportional Hazards Models | 1 | 2019 | 1105 | 0.130 |
Why?
| | Intubation, Intratracheal | 1 | 1997 | 220 | 0.130 |
Why?
| | Dietary Supplements | 1 | 2019 | 466 | 0.130 |
Why?
| | Lung Diseases | 1 | 2021 | 693 | 0.120 |
Why?
| | Palliative Care | 1 | 2020 | 622 | 0.120 |
Why?
| | Time Factors | 3 | 2021 | 6240 | 0.120 |
Why?
| | Blood Pressure | 1 | 2019 | 1618 | 0.110 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 1114 | 0.110 |
Why?
| | Wounds and Injuries | 1 | 2019 | 659 | 0.100 |
Why?
| | Adult | 3 | 2023 | 31003 | 0.100 |
Why?
| | Bile Duct Neoplasms | 1 | 2011 | 55 | 0.100 |
Why?
| | Microfilament Proteins | 2 | 2003 | 129 | 0.100 |
Why?
| | Diastole | 2 | 2022 | 142 | 0.090 |
Why?
| | Drainage | 1 | 2011 | 152 | 0.090 |
Why?
| | Purines | 2 | 2022 | 161 | 0.090 |
Why?
| | Cell Count | 1 | 2010 | 308 | 0.090 |
Why?
| | Anastomosis, Surgical | 2 | 2021 | 141 | 0.090 |
Why?
| | Actins | 2 | 2003 | 386 | 0.090 |
Why?
| | Swine | 2 | 2022 | 714 | 0.080 |
Why?
| | Cholestasis | 1 | 2011 | 226 | 0.080 |
Why?
| | Metabolome | 2 | 2021 | 287 | 0.080 |
Why?
| | Peptide Fragments | 2 | 2003 | 683 | 0.080 |
Why?
| | Carrier Proteins | 2 | 2003 | 719 | 0.080 |
Why?
| | Stents | 1 | 2011 | 473 | 0.080 |
Why?
| | Keratan Sulfate | 1 | 2006 | 1 | 0.070 |
Why?
| | Histidine | 2 | 2003 | 62 | 0.070 |
Why?
| | Synovial Fluid | 1 | 2006 | 56 | 0.070 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2006 | 135 | 0.060 |
Why?
| | Hyaluronic Acid | 1 | 2006 | 195 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2020 | 3361 | 0.060 |
Why?
| | Osteoarthritis | 1 | 2006 | 175 | 0.060 |
Why?
| | Erythrocyte Membrane | 1 | 2003 | 53 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2010 | 2236 | 0.060 |
Why?
| | Serine | 1 | 2003 | 130 | 0.060 |
Why?
| | Binding Sites | 2 | 2003 | 1206 | 0.050 |
Why?
| | Molecular Structure | 1 | 2003 | 434 | 0.050 |
Why?
| | Morbidity | 1 | 2023 | 283 | 0.050 |
Why?
| | Circulatory Arrest, Deep Hypothermia Induced | 1 | 2022 | 20 | 0.050 |
Why?
| | Tadalafil | 1 | 2022 | 7 | 0.050 |
Why?
| | Amino Acid Sequence | 2 | 2003 | 2032 | 0.050 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2022 | 36 | 0.050 |
Why?
| | Molecular Sequence Data | 2 | 2003 | 2817 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 19 | 0.050 |
Why?
| | Models, Molecular | 2 | 2003 | 1405 | 0.050 |
Why?
| | Niacinamide | 1 | 2021 | 69 | 0.050 |
Why?
| | Arterial Pressure | 1 | 2021 | 97 | 0.050 |
Why?
| | Methionine | 1 | 2021 | 145 | 0.050 |
Why?
| | Gestational Age | 1 | 2023 | 766 | 0.050 |
Why?
| | Survival Rate | 2 | 2011 | 1679 | 0.050 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2020 | 39 | 0.040 |
Why?
| | Patient-Specific Modeling | 1 | 2020 | 37 | 0.040 |
Why?
| | Coronary Circulation | 1 | 2020 | 118 | 0.040 |
Why?
| | Systole | 1 | 2020 | 172 | 0.040 |
Why?
| | Principal Component Analysis | 1 | 2020 | 181 | 0.040 |
Why?
| | Phosphorylation | 1 | 2003 | 1590 | 0.040 |
Why?
| | Aortic Valve | 1 | 2022 | 355 | 0.040 |
Why?
| | Time | 1 | 2019 | 75 | 0.040 |
Why?
| | Electrocardiography | 1 | 2022 | 548 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2022 | 965 | 0.040 |
Why?
| | Chromatography, Liquid | 1 | 2020 | 350 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1394 | 0.040 |
Why?
| | Serotonin | 1 | 2020 | 298 | 0.040 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 1999 | 238 | 0.040 |
Why?
| | Aorta | 1 | 2020 | 358 | 0.040 |
Why?
| | Myocardium | 1 | 2023 | 944 | 0.040 |
Why?
| | Electrophysiologic Techniques, Cardiac | 1 | 2018 | 70 | 0.040 |
Why?
| | Arthritis, Rheumatoid | 1 | 2006 | 993 | 0.040 |
Why?
| | Nevada | 1 | 1997 | 7 | 0.040 |
Why?
| | Poisson Distribution | 1 | 1997 | 67 | 0.040 |
Why?
| | Blood Flow Velocity | 1 | 2018 | 325 | 0.040 |
Why?
| | Mass Spectrometry | 1 | 2020 | 661 | 0.040 |
Why?
| | Confidence Intervals | 1 | 1997 | 314 | 0.030 |
Why?
| | Intensive Care Units, Pediatric | 1 | 1997 | 155 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2018 | 497 | 0.030 |
Why?
| | Kidney | 1 | 2022 | 1344 | 0.030 |
Why?
| | Hospital Mortality | 1 | 2018 | 795 | 0.030 |
Why?
| | Oxygen | 1 | 2018 | 828 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2023 | 2403 | 0.030 |
Why?
| | Cohort Studies | 1 | 2023 | 5051 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2021 | 4507 | 0.030 |
Why?
| | Animals | 3 | 2022 | 32737 | 0.020 |
Why?
| | Retreatment | 1 | 2011 | 71 | 0.020 |
Why?
| | Age Factors | 1 | 2018 | 2951 | 0.020 |
Why?
| | Incidence | 1 | 1997 | 2377 | 0.020 |
Why?
| | Catheterization | 1 | 2011 | 158 | 0.020 |
Why?
| | Radiography, Interventional | 1 | 2011 | 111 | 0.020 |
Why?
| | Risk Assessment | 1 | 2018 | 3021 | 0.020 |
Why?
| | Bone Morphogenetic Protein 7 | 1 | 2006 | 9 | 0.020 |
Why?
| | Young Adult | 1 | 2020 | 10675 | 0.020 |
Why?
| | Reference Values | 1 | 2006 | 751 | 0.020 |
Why?
| | Autoantigens | 1 | 2006 | 397 | 0.010 |
Why?
| | Knee Joint | 1 | 2006 | 343 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2011 | 6453 | 0.010 |
Why?
| | Titrimetry | 1 | 1999 | 9 | 0.010 |
Why?
| | Consensus Sequence | 1 | 1999 | 70 | 0.010 |
Why?
| | Static Electricity | 1 | 1999 | 117 | 0.010 |
Why?
| | Solvents | 1 | 1999 | 108 | 0.010 |
Why?
| | Chickens | 1 | 1999 | 183 | 0.010 |
Why?
| | Amino Acid Motifs | 1 | 1999 | 199 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 1999 | 332 | 0.010 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1999 | 523 | 0.010 |
Why?
| | Protein Folding | 1 | 1999 | 248 | 0.010 |
Why?
| | Thermodynamics | 1 | 1999 | 382 | 0.010 |
Why?
| | Protein Binding | 1 | 1999 | 1949 | 0.010 |
Why?
| | Aged | 1 | 2011 | 19358 | 0.010 |
Why?
| | Middle Aged | 1 | 2011 | 27172 | 0.010 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|